Medicare now covers GLP-1 weight-loss drugs for just a $50 co-pay

Starting July 1, Medicare launched the GLP-1 Bridge Program, allowing Americans to access GLP-1 weight-loss medications for a $50 co-pay. The one-year program could open the door for millions of previously priced-out patients to use drugs like Ozempic or Wegovy. Analysts say the move could permanently reshape how obesity is treated in the United States.